We are live on ! Find out more
KYMR icon

Kymera Therapeutics
KYMR

136 hedge funds and large institutions have $1.55B invested in Kymera Therapeutics in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 36 increasing their positions, 53 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

354% more call options, than puts

Call options by funds: $1.97M | Put options by funds: $433K

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

94% more capital invested

Capital invested by funds: $797M → $1.55B (+$753M)

83% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 18

12% more funds holding

Funds holding: 121 → 136 (+15)

6.24% more ownership

Funds ownership: 103.5% → 109.74% (+6.2%)

32% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 53

Holders
136
Holders Change
+15
Holders Change %
+12.4%
% of All Funds
1.98%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
33
Increased
36
Reduced
53
Closed
18
Calls
$1.97M
Puts
$433K
Net Calls
+$1.53M
Net Calls Change
+$913K

Top Buyers

1
BBA
Baker Bros. Advisors
New York
+$22.3M
2
AG
Artal Group
Luxembourg
+$13M
3
Morgan Stanley
Morgan Stanley
New York
+$9.71M
4
Goldman Sachs
Goldman Sachs
New York
+$8.4M
5
SSA
Schonfeld Strategic Advisors
New York
+$7.83M

Top Sellers

1
WA
Wasatch Advisors
Utah
-$7.96M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.01M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$5.63M
4
American Century Companies
American Century Companies
Missouri
-$3.79M
5
CS
Candriam SCA
Luxembourg
-$2.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$153M +$22.3M +1,245,528 +26%
AVLSA
2
Atlas Venture Life Science Advisors
Massachusetts
$149M – – –
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$136M +$4.98M +278,287 +6%
BI
4
BVF Inc
California
$131M +$7.56M +422,797 +9%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$123M -$139K -7,771 -0.2%
Vanguard Group
6
Vanguard Group
Pennsylvania
$102M +$1.29M +72,351 +2%
ACA
7
Avoro Capital Advisors
New York
$96.1M -$1.43M -80,000 -2%
BlackRock
8
BlackRock
New York
$90.8M +$3.73M +208,727 +6%
AG
9
Artal Group
Luxembourg
$64.4M +$13M +725,389 +40%
State Street
10
State Street
Massachusetts
$48.2M -$1.64M -91,607 -5%
RG
11
Redmile Group
California
$46.4M -$797K -44,551 -2%
RSCM
12
Rock Springs Capital Management
Maryland
$38.8M +$320K +17,887 +1%
T. Rowe Price Investment Management
13
T. Rowe Price Investment Management
Maryland
$33M -$5.63M -314,553 -20%
Morgan Stanley
14
Morgan Stanley
New York
$22.5M +$9.71M +543,228 +160%
ACM
15
Aquilo Capital Management
California
$22.4M +$1.77M +99,118 +13%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$22.4M +$828K +46,288 +6%
Goldman Sachs
17
Goldman Sachs
New York
$17.2M +$8.4M +469,947 +230%
DMC
18
Deer Management Company
New York
$15.7M – – –
Fidelity Investments
19
Fidelity Investments
Massachusetts
$13.6M -$6.01M -335,947 -39%
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$13.6M -$2.17M -121,504 -19%
JP Morgan Chase
21
JP Morgan Chase
New York
$13M -$1.96M -109,746 -18%
Norges Bank
22
Norges Bank
Norway
$12.8M +$6.91M +386,200 +328%
Massachusetts Financial Services
23
Massachusetts Financial Services
Massachusetts
$11.8M -$15.3K -858 -0.2%
SSA
24
Schonfeld Strategic Advisors
New York
$11.1M +$7.83M +437,633 New
Barclays
25
Barclays
United Kingdom
$9.72M -$138K -7,695 -2%
1
2 3 4 5

KYMR Hedge Fund Activity: Q4 2023 in Review

136 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Kymera Therapeutics (KYMR) for Q4 2023, worth a combined $1.55B — up 94% from $797M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new KYMR positions and 18 closed out — a net gain of 15 holders — while 36 added to existing stakes and 53 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $22.3M. The largest seller was Wasatch Advisors, exiting entirely with an estimated $7.96M sold.

  • 136 institutional investors held Kymera Therapeutics (KYMR) as of Q4 2023, up from 121 in Q3 2023.
  • Funds reported $1.55B of Kymera Therapeutics stock for Q4 2023, up 94% quarter-over-quarter.
  • 33 funds opened new Kymera Therapeutics positions in Q4 2023 and 18 closed out, a net change of +15 holders.
  • The largest Kymera Therapeutics buyer in Q4 2023 was Baker Bros. Advisors, an estimated $22.3M added.
  • The largest Kymera Therapeutics seller in Q4 2023 was Wasatch Advisors, an estimated $7.96M sold.

Based on aggregated 13F filings for Q4 2023.